The salt form is the delivery vehicle
Efforts continue to refine receptor targeting
Current incretin medicines include GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists
On average, tirzepatide led to a superior weight loss of 20.2% compared to 13.7% with semaglutide
Here are some of the signs of B12 deficiency to look out for: Numbness, tingling, or a pins and needles feeling in the hands or feet (even if slight or minor) Falling or losing your footing more than usual or without reason Not being able to stay balanced Stiff muscles Vision changes Symptoms of psychosis (e.g., hallucinations, paranoia, disorganized thoughts, or schizophrenia-like symptoms) Severe or unusual tiredness Memory issues Sometimes, these symptoms can develop gradually
Each generation of incretin therapy produces greater weight loss than the last